Aquestive Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Aquestive Therapeutics's estimated annual revenue is currently $6.7M per year.
- Aquestive Therapeutics received $73.9M in venture funding in August 2018.
- Aquestive Therapeutics's estimated revenue per employee is $56,639
- Aquestive Therapeutics's total funding is $199.6M.
Employee Data
- Aquestive Therapeutics has 119 Employees.
- Aquestive Therapeutics grew their employee count by -37% last year.
Aquestive Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | SVP General Counsel | Reveal Email/Phone |
4 | SVP, General Counsel | Reveal Email/Phone |
5 | VP, Head Finance | Reveal Email/Phone |
6 | Head Regulatory Project Management | Reveal Email/Phone |
7 | SVP Research Development | Reveal Email/Phone |
8 | SVP Business Process and IT | Reveal Email/Phone |
9 | Head Recruitment | Reveal Email/Phone |
10 | VP, Pricing & Market Access | Reveal Email/Phone |
Aquestive Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Aquestive Therapeutics?
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people's lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.
keywords:N/A
$199.6M
Total Funding
119
Number of Employees
$6.7M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aquestive Therapeutics News
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet...
Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system, or CNS, and an...
Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system, or CNS, and an...
Aquestive Therapeutics Inc (NASDAQ:AQST) was the target of a significant decline in short interest during the month of July. As of July 31st, ...
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST): Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, ...
Other Companies in Warren
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $29.2M | 119 | 6% | N/A |
#2 | $15M | 119 | 4% | N/A |
#3 | $35M | 119 | 1% | N/A |
#4 | $35M | 121 | 4% | N/A |
#5 | $20M | 121 | N/A | N/A |
Aquestive Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-08-16 | $73.9M | Undisclosed | BMO Capital Markets | Article |